The healthcare industry’s growth is driven by the fast-rising medical needs, the growing demand for personalized and precision drugs, and the use of advanced technologies.
Given this backdrop, investors could consider buying undervalued healthcare stocks such as AbbVie Inc. (ABBV), Bristol-Myers Squibb Company (BMY), and Gilead Sciences, Inc. (GILD), given their high potential. Before diving deeper into the fundamentals of these stocks, let’s discuss what’s shaping the healthcare industry’s prospects.
